Speed
80 days to first decision for reviewed manuscripts only
78 days to first decision for all manuscripts
133 days from submission to acceptance
16 days from acceptance to publication
Usage
74,526 Downloads
59 Altmetric mentions
Page 1 of 2
Asthma is a heterogeneous disease, usually characterized by chronic airway inflammation, bronchial reversible obstruction and hyperresponsiveness to direct or indirect stimuli. It is a severe disease causing a...
Citation: Asthma Research and Practice 2021 7:3
The association between caries index, which is diagnosed by Decayed, Missing, and Filled Teeth (DMFT), and asthma has been assessed in several studies, which yielded contradictory results. Meta-analysis is the...
Citation: Asthma Research and Practice 2021 7:2
The treatment with short-acting beta-2 agonists (SABA) alone is no longer recommended due to safety issues. Instead, the current Global Initiative for Asthma (GINA) Report recommends the use of the combination...
Citation: Asthma Research and Practice 2021 7:1
Research has documented that housing conditions can negatively impact the health of residents. Asthma has many known indoor environmental triggers including dust, pests, smoke and mold, as evidenced by the 25 ...
Citation: Asthma Research and Practice 2020 6:13
Medication non-adherence is one of a common problem in asthma management and it is the main factor for uncontrolled asthma. It can result in poor asthma control, which leads to decreased quality of life, incre...
Citation: Asthma Research and Practice 2020 6:12
According to the World Health Organization (WHO), the outbreak of coronavirus disease in 2019 (COVID-19) has been declared as a pandemic and public health emergency that infected more than 5 million people wor...
Citation: Asthma Research and Practice 2020 6:11
An amendment to this paper has been published and can be accessed via the original article.
Citation: Asthma Research and Practice 2020 6:10
The Global Initiative for Asthma (GINA)-defined criteria for asthma control include questions about daytime symptoms, limitation of activity, nocturnal symptoms, need for reliever treatment and patients’ satisfac...
Citation: Asthma Research and Practice 2020 6:9
Coronavirus disease 2019 outbreak is the first reported case in Wuhan, China in December 2019 and suddenly became a major global health concern. According to the European Centre for Disease Prevention and Cont...
Citation: Asthma Research and Practice 2020 6:8
Although asthma is a serious public health concern in Zimbabwe, there is lack of information regarding the decision to seek for healthcare services among patients. This study aimed to determine the health care...
Citation: Asthma Research and Practice 2020 6:7
Short-acting β2-agonist (SABA) nebulization is commonly prescribed for children hospitalized with severe asthma exacerbation. Either intermittent or continuous delivery has been considered safe and efficient. ...
Citation: Asthma Research and Practice 2020 6:6
Exercise is recommended in guidelines for asthma management and has beneficial effects on symptom control, inflammation and lung function in patients with sub-optimally controlled asthma. Despite this, physica...
Citation: Asthma Research and Practice 2020 6:5
Asthma affects the lives of hundred million people around the World. Despite notable progresses in disease management, asthma control remains largely insufficient worldwide, influencing patients’ wellbeing and...
Citation: Asthma Research and Practice 2020 6:4
Asthma is a chronic airway inflammation disease that is frequently found in children and adolescents with an increasing prevalence. Several studies are linking its presence to many lifestyle and health correla...
Citation: Asthma Research and Practice 2020 6:3
Anti-IgE (omalizumab) and anti-IL5/IL5R (reslizumab, mepolizumab and benralizumab) treatments are available for severe allergic and eosinophilic asthma. In these patients, studies have shown beneficial effects...
Citation: Asthma Research and Practice 2020 6:2
Acute asthma attack is one of the most common causes of visits to hospital emergency departments in all age groups of the population and accounts for the greater part of healthcare burden from the disease. Des...
Citation: Asthma Research and Practice 2020 6:1
Asthma is one of the major non-communicable diseases worldwide. The prevalence of asthma has continuously increased over the last five decades, resulting in 235 million people suffering from it. One of the mai...
Citation: Asthma Research and Practice 2019 5:5
Asthma accounts for significant global morbidity and health-care costs. It is still poorly understood among health professionals and the general population. Consequently, there are significant morbidity and mo...
Citation: Asthma Research and Practice 2019 5:4
Childhood asthma is a growing clinical problem and a burden on the health care system due to repetitive visits to children’s emergency departments and frequent hospital admissions where it is poorly controlled...
Citation: Asthma Research and Practice 2019 5:3
The prevalence of chronic diseases in the elderly (> 65 years), including asthma, is growing, yet information available on asthma in this population is scarce.
Citation: Asthma Research and Practice 2019 5:2
Asthma is a chronic inflammatory lung disease that affects 18.7 million U.S. adults. Electronic health records (EHRs) are a unique source of information that can be leveraged to understand factors associated w...
Citation: Asthma Research and Practice 2019 5:1
Although asthma is one of the most serious diseases causing complications during pregnancy, half of the women discontinue therapy thus diminishing the control of the disease, mostly due to the inadequate educa...
Citation: Asthma Research and Practice 2018 4:11
Asthma is a heterogenous disease characterized by multiple phenotypes driven by different mechanisms. The implementation of precision medicine in the management of asthma requires the identification of phenoty...
Citation: Asthma Research and Practice 2018 4:10
Asthma is a chronic condition usually characterized by underlying inflammation. The study of asthmatic inflammation is of the utmost importance for both diagnostic and monitoring purposes. The gold standard fo...
Citation: Asthma Research and Practice 2018 4:9
Recurrent exacerbations in patients with moderate or severe asthma are the major causes of morbidity, mortality and medical expenditure. Identifying predictors of frequent asthma attack might offer the fertile...
Citation: Asthma Research and Practice 2018 4:8
The combination of budesonide + formoterol (BFC) offers the advantages of dose adjustment in a single inhaler according to asthma symptoms. We analyzed the relationship between asthma symptoms in terms of peak...
Citation: Asthma Research and Practice 2018 4:7
Asthma in paediatric populations is one of the highest public health concerns. In this study of children and adolescents, we hypothesized that low levels of physical activity (PA) would show associations with ...
Citation: Asthma Research and Practice 2018 4:6
To date, few studies have focused on the clinical and allergic characteristics of asthma in the elderly, defined as asthma in people aged 60 or over. Thus, we propose to identify and study the clinical and all...
Citation: Asthma Research and Practice 2018 4:5
Genetic variations in different loci and genes are important in asthma pathogenesis. There is much importance of various immunological pathways in the IgE secretion regulation. Alterations in any main part of ...
Citation: Asthma Research and Practice 2018 4:4
Asthma is a worldwide common chronic airway disease that cannot be cured and results in the huge burden in public health. Oxidative stress was considered an important mechanism in the pathogenesis of asthma. H...
Citation: Asthma Research and Practice 2018 4:3
Misconceptions about medications’ safety can lead pregnant women with asthma to stop their medications, resulting in asthma-related neonatal morbidity and mortality. Our aim was to assess the level of pregnanc...
Citation: Asthma Research and Practice 2018 4:2
The mucosal immune system is in constant communication with the vast diversity of microbes present on body surfaces. The discovery of novel molecular mechanisms, which mediate host-microbe communication, have ...
Citation: Asthma Research and Practice 2018 4:1
Patients with allergic rhinitis often trivialise their condition, self-manage inappropriately, and would benefit from health care intervention. The primary point of health care contact for these self-managing ...
Citation: Asthma Research and Practice 2017 3:8
Asthma is a chronic inflammatory condition of the airways that affects roughly 358 million people globally. It is a serious global health problem with an increasing prevalence worldwide. Most people affected a...
Citation: Asthma Research and Practice 2017 3:7
Many studies have evaluated associations between asthma emergency department (ED) visits, hospital admissions (HAs), and ambient ozone (O3) across the US, but not in Texas. We investigated the relationship betwee...
Citation: Asthma Research and Practice 2017 3:6
Prior evidence suggests that vitamin D deficiency may increase the risk of asthma and atopy and impair pulmonary function in children.
Citation: Asthma Research and Practice 2017 3:5
Asthma is reported as one of the most common chronic diseases in childhood, impairing the quality of life of patients and their families and incurring high costs to the healthcare system and society. Despite t...
Citation: Asthma Research and Practice 2017 3:4
Little is known about asthma in the elderly as most studies of this condition have not included this patient group. It is unclear whether leukotriene antagonists benefit older asthmatics. We studied the effect...
Citation: Asthma Research and Practice 2017 3:3
Asthma, a chronic respiratory disease affecting over 18.7 million American adults, has marked disparities by gender, race/ethnicity and socioeconomic status. Our goal was to identify gender-specific demographi...
Citation: Asthma Research and Practice 2017 3:2
In recent decades, both asthma prevalence and incidence have been increasing worldwide, not only due to the genetic background, but mainly because of the effect of a wide number of environmental and lifestyle ...
Citation: Asthma Research and Practice 2017 3:1
Food allergic individuals are exposed to unnecessary dietary restrictions due to precautionary food allergy labelling (PFAL). Two forms of PFAL exist: type I identifies the possible presence of allergenic cont...
Citation: Asthma Research and Practice 2016 2:13
Evidence that enables us to identify, assess, and access the small airways in asthma and chronic obstructive pulmonary disease (COPD) has led INTERASMA (Global Asthma Association) and WAO to take a position on...
Citation: Asthma Research and Practice 2016 2:12
Asthma is a heterogeneous disease, usually characterized by chronic airway inflammation and a variable course associated with various underlying mechanisms that can differ between individuals. Patients with as...
Citation: Asthma Research and Practice 2016 2:11
Asthma is still a major public health problem in most countries; new strategies to better control this disease are necessary. Such strategies must include predisposing factors. One of these factors is smoking ...
Citation: Asthma Research and Practice 2016 2:10
Molecular based in vitro technologies greatly changed the diagnostic approaches in allergy. At present, sensitization profiles can be dissected according to IgE subsets, which are specific for genuine or cross...
Citation: Asthma Research and Practice 2016 2:9
Asthma management in Australia is suboptimal. The “Guidelines for provision of a Pharmacist Only medicine: short acting beta agonists” (SABA guidelines) and a novel West Australian “Asthma Action Plan card” (AAP ...
Citation: Asthma Research and Practice 2016 2:8
Child maltreatment is a common problem with known adverse consequences, yet its contributions to the development and course of pediatric asthma are only poorly understood.
Citation: Asthma Research and Practice 2016 2:7
Asthma is a disease encompassing a variety of contributing factors. Phenotyping of asthma based on the profile of accumulated granulocytes in the airways has been performed to explore the mediators involved in...
Citation: Asthma Research and Practice 2016 2:6
In the present review, we focus on evidence-based data for the use of inhaled corticosteroids (ICS), leukotriene receptor antagonist (LTRA), long-acting beta2-agonits (LABA) and oral corticosteroids (OCS), wit...
Citation: Asthma Research and Practice 2016 2:5
Fluticasone furoate (FF)/vilanterol (VI) is a once-daily inhaled corticosteroid (ICS)/long-acting beta2 agonist (LABA) combination. FF/VI, 92/22mcg and 184/22mcg, are approved in Europe as maintenance therapy in ...
Citation: Asthma Research and Practice 2016 2:4
Speed
80 days to first decision for reviewed manuscripts only
78 days to first decision for all manuscripts
133 days from submission to acceptance
16 days from acceptance to publication
Usage
74,526 Downloads
59 Altmetric mentions